Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +44.28%
#3 ADO Protocol ADO Protocol +38.90%
#4 Prom Prom +36.15%
#5 Pons Pons +33.67%
#6 Collector Crypt Collector Crypt +27.99%
#7 StonkBroker StonkBroker +27.88%
#8 TENDIES TENDIES +25.93%
#9 龙虾 (Lobster) 龙虾 (Lobster) +21.78%
#10 Cysic Cysic +20.02%
Coin of the day
GEKKO GEKKO
Innstillinger
Språk
NORSK
Valuta
USD
Tema
MedCap AB (publ) MedCap AB (publ)

MedCap AB (publ)

MCAP
Rangering i aksjer #9767
MedCap AB (publ) operates as a private equity firm, employing a diverse array... MedCap AB (publ) operates as a private equity firm, employing a diverse array of investment strategies including secondary direct deals, later-stage funding, industry consolidation, growth capital provision, engagement with middle-market and mature businesses, turnarounds, and outright buyouts. The company primarily directs its capital towards businesses within the healthcare sector, focusing on medical equipment and services, biotechnology, life sciences, and pharmaceuticals. It actively seeks unlisted, small to mid-sized companies located predominantly across Northern Europe. Equity investments typically fall within the SEK 25 million to SEK 150 million range (approximately $2.75 million to $16.51 million). Target companies generally exhibit an enterprise value and annual sales revenue between SEK 50 million and SEK 200 million ($5.90 million to $23.06 million), alongside an EBITDA of SEK 1 million to SEK 50 million ($0.11 million to $5.50 million). MedCap aims to acquire ownership stakes of 20% to 50% in its portfolio entities, financing these through its own capital, loans, and direct balance sheet investments. Established in 2001, the firm maintains its headquarters in Stockholm, Sweden.
Aksjekurs
$63.50
Sist synkronisert: 2026-08-28
Markedsverdi
$950.92M
Endring (1 dag)
3.27%
Endring (1 år)
-2.15%
Land
SE
Handel MedCap AB (publ) (MCAP)

Kategori

Healthcare
P/E-forhold for MedCap AB (publ) (MCAP)
P/E-forhold per 2026 TTM: 0
Ifølge MedCap AB (publ) sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for MedCap AB (publ) fra 2026 til 2026
P/E-forhold ved slutten av hvert år
År P/E-forhold Endre
Ikke nok data for de angitte datoene.
P/E-forhold for lignende selskaper eller konkurrenter
Selskap P/E-forhold Forskjell i P/E-forhold Land
BlackRock, Inc. BlackRock, Inc.
BlackRock, Inc.
BLK.US
 27.69 -
US
Blackstone Inc. Blackstone Inc.
Blackstone Inc.
BX.US
 31.99 -
US
Investor AB (publ) Investor AB (publ)
Investor AB (publ)
INVE-A.ST
 - -
SE
KKR & Co. Inc. KKR & Co. Inc.
KKR & Co. Inc.
KKR.US
 33.93 -
US
Brookfield Asset Management Ltd. Brookfield Asset Management Ltd.
Brookfield Asset Management Ltd.
BAM.US
 31.21 -
US
Hvordan lese en P/E-ratio?

Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.

Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.

Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.